The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges
Simple Summary Immunotherapy has improved outcomes for people with non-small-cell lung cancer, but some patients do not benefit or develop resistance during treatment. Blood tests known as liquid biopsies may help monitor cancer by detecting tumor-derived DNA and other circulating signals. This review examines their po...